Europe PMC
metadata only
A Whole Genomic CRISPR/Cas9 Screen Identifies the Amino Acid Transporter SLC43A1 (LAT3) as a Major Determinant of Oxaliplatin Sensitivity in Colorectal Cancer Cells
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad#1171741
- Supplementary Datasets underlying analysis and results presented in<b>CRISPR-enhanced assessment of variants of unknown significance nominates oncology therapeutic targets and drug repositioning opportunities</b>. Savino et Al. 2026#642725
- Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer#915703
- CRISPR enzymes and systems — The Broad Institute, Inc. (US12305204B2)#607486
- A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer#832104
Record · ID 485210
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive